ライフサイエンスコーパス: to a maximum

1 xpression and monocyte recruitment also rose to a maximum.

2 pproximately 3-fold) in the queens; and rose to a maximum (13-fold) in workers.

3 to approximately 50% Po, then rising sharply to a maximum (16 +/- 0.8 s-1) in fully activated fibers.

4 the start of the dark period, then increased to a maximum 2 h before dawn.

5 s, cell-cycle-specific mRNA expression leads to a maximum 2-fold change in protein content compared t

6 r inhibitor nomifensine increases resting DA to a maximum 207 +/- 16 nM at 28 +/- 2 min following inj

7 in an increased local concentration, leading to a maximum 300-fold increase in the reaction rate.

8 The autoinduction leads to a maximum 4-fold signal enhancement for each fluoride

9 ms, the efficacy of the e-scaffold increased to a maximum (8.27 +/- 0.05) log reduction in A. baumann

10 e injured kidneys 12 h after injury and rose to a maximum after 1 d, exceeding the control values by

11 aged <14 years were analyzed retrospectively to a maximum age of 18 years, with a minimal observation

12 ation and (13)CO(2) discrimination increased to a maximum and then declined; delta(18)O(TW) increased

13 te of curvature, with both values increasing to a maximum and then declining as the roots approached

14 wth rates that are initially low, accelerate to a maximum, and decrease again.

15 ensities, the intensity of C(red1) increased to a maximum, and then declined as the intensities of C(

16 action potential, I(Kr) increased gradually to a maximum at -55 to -60 mV.

17 nt increase in signaling and transformation, to a maximum at 14 times the wild-type KSR1 expression l

18 Similarly, cortical TSPO binding increased to a maximum at 14.5 mo (+15%, P < 0.001) and remained h

19 ic effects on the kSS, which first increased to a maximum at 200 msec and then decreased with longer

20 in culture was shown to accumulate with time to a maximum at 4 h.

21 2 activity rises quickly after fertilization to a maximum at 4 min, corresponding in timing to the ea

22 hybridization using 1ng of target increased to a maximum at 4h and that using 10ng of target did not

23 In contrast, LDF responses increased to a maximum at 5 Hz, and do not correlate with SEPs.

24 ratumoral doxorubicin accumulation increased to a maximum at 72 h with greater uptake in the RF-ablat

25 on in embryonic hearts, increasing in number to a maximum at about postnatal day (PN) 2; thereafter,

26 ncreasing lifetimes with increasing loads up to a maximum at approximately 6 pN.

27 y of silver staining progressively increased to a maximum at four days post ischemia, while the ampli

28 trol animals, the levels of NGF rose rapidly to a maximum at one week and then slowly declined over t

29 tion begins in prophase/diplotene, increases to a maximum at prometaphase-metaphase, and drops during

30 synchronous with the FPs markedly increased to a maximum at the ictal onset.

31 iring frequency rose very suddenly from zero to a maximum at the onset of muscle shortening and conti

32 5 clones, ranging from just above background to a maximum at the ori-beta locus.

33 e concentration of bromochloramine increased to a maximum before decreasing gradually.

34 Conversely, under assisting loads V(F) rises to a maximum before decreasing monotonically.

35 ially decreased following the cue, then rose to a maximum before falling to below baseline levels.

36 S. imperator is estimated to have grown to a maximum body length of at least 11 to 12 meters and

37 ers from the beginning of its development up to a maximum concentration (1,789 mumol/Kg FW).

38 rance against the presence of copper ions up to a maximum concentration of 0.80 muM (equivalent to 50

39 I forms through photoinduced CS, accumulates to a maximum concentration, then dies away through CR.

40 ll parameters with changing rhodium content, to a maximum content of 3 % dopant.

41 K-exchanged montmorillonite swells rapidly to a maximum d(001) of approximately 12.2 A.

42 e treatment for 6 weeks (0.5 mg/day titrated to a maximum daily dose of 2.5 mg).

43 nd in healthy subjects titrated over 3 weeks to a maximum daily oxcarbazepine dose of 2,400mg.

44 dive very deeply on occasion (one descended to a maximum depth of 1,230 metres, which represents the

45 d the sediment, progressing inward with time to a maximum depth of 10000 mum and indicating microbial

46 esults suggest that limiting bottom trawling to a maximum depth of 600 m could be an effective manage

47 he number of resolved dynamics components up to a maximum determined by the amount of noise.

48 wetting surface of this type will spread out to a maximum diameter and then recoil to such an extent

49 ative assembly and range in size from ~50 nm to a maximum diameter of ~1,000 nm.

50 H cuts in the donor RNA allowed propagation to a maximum distance of 32-64 nt.

51 grain size near 1 mum and can be attributed to a maximum domain wall density and mobility.

52 stments on the basis of platelet response up to a maximum dosage of 75 mg per day.

53 50 mg, which could be increased, as needed, to a maximum dose of 150 mg daily, for a total of 12 wee

54 topiramate doses were titrated over 6 weeks to a maximum dose of 150 mg twice daily.

55 of toxicity, a dose escalation of paclitaxel to a maximum dose of 170 mg/m(2)/d was prescribed.

56 day 2; and vincristine (1.5 mg/m(2) per day to a maximum dose of 2 mg, or 0.05 mg/kg per day for chi

57 t A), or 2 x 10(6) cells per kg body weight, to a maximum dose of 2 x 10(8) cells per infusion (cohor

58 nts received riociguat individually adjusted to a maximum dose of 2.5 mg three times a day.

59 nts received riociguat individually adjusted to a maximum dose of 2.5 mg three times per day.

60 week, depending on weight, and then titrated to a maximum dose of 20 or 30 mg/d over 4 weeks.

61 eks at an initial dose of 50 mg/d (escalated to a maximum dose of 200 mg/d based on tolerability and

62 kg per day, up-titrated until intolerance or to a maximum dose of 25 mg/kg or 50 mg/kg per day (depen

63 nerinetide in a single dose of 2.6 mg/kg, up to a maximum dose of 270 mg, on the basis of estimated o

64 a 1:1 ratio to receive gabapentin (titrated to a maximum dose of 2700 mg daily) or matching placebo

65 or matching placebo dose adjusted from 50 mg to a maximum dose of 300 mg.

66 mg/m(2)/d with intrapatient dose escalation to a maximum dose of 300 mg/m(2)/d.

67 omide was started at 200 mg/d, and escalated to a maximum dose of 400 mg/d.

68 mg/m(2)/d, with intrapatient dose escalation to a maximum dose of 500 mg/m(2)/d.

69 MAS-ER doses were titrated over 2 weeks to a maximum dose of 60 mg daily, and topiramate doses w

70 t a dose of 150 mg per day that was adjusted to a maximum dose of 600 mg per day or matching placebo

71 QTc lengthened from 377 +/- 9 ms (baseline) to a maximum during hypoglycemia of 439 +/- 13 ms in BRS

72 cular materials is not dominated by a return to a maximum entropic state, but is mostly the result of

73 To increase benefit to a maximum, every effort should be taken to shorten de

74 ailure to form the thiol ester (Asn --> Asp) to a maximum extent of formation of about 50% (Asn --> A

75 sulted in a slow intracellular acidification to a maximum fall of about 0.26 pH units and a 72 % incr

76 current injections, which induced firing up to a maximum firing frequency of 310 Hz.

77 early with depth, while shoot size increases to a maximum followed by a decline.

78 With stronger stimuli, the response rose to a maximum for very low firing rates, but then decreas

79 FRET increased with protein concentration up to a maximum (FRET(max)) that was taken to represent the

80 ca. twofold from low levels in swarmer cells to a maximum immediately prior to cell division, while d

81 a 4 min incubation in the capture wells led to a maximum in JEG-3 cell settling on the surface (71 +

82 ut the length of all chromosomes, increasing to a maximum in late anaphase.

83 ve-SS of 12 dynes/cm(2), whereas ICAM-1 rose to a maximum in parallel with SS.

84 Rather, the cross-sectional mass increases to a maximum in the center of each fibril.

85 the frequency of A+N- increased from age 50 to a maximum in the mid-70s and declined thereafter; and

86 9 microm, superior), thickened progressively to a maximum in the midperiphery approximately 600 to 10

87 absent in the first section, then increased to a maximum in the oldest sections.

88 hat resulted in an increase in the 3:4 ratio to a maximum in which 4 was nearly completely suppressed

89 d progressively with oligosaccharide size up to a maximum length of a tetradecasaccharide.

90 dose was increased 25 mg/day (as tolerated) to a maximum level of 550 mg/day.

91 e Rib-1,5-P2 concentration rapidly increased to a maximum level of 8.0 +/- 0.9 nmol/g cell 30 s after

92 st misinterpretation of results, as compared to a maximum likelihood estimate based approach.

93 ering operations which are shown to converge to a maximum likelihood parameter estimate.

94 te (NHLBI) Family Heart Study were subjected to a maximum likelihood-based factor analysis.

95 the likelihood of the growth rate and leads to a maximum-likelihood estimate.

96 tic information in a fashion that is similar to a maximum-likelihood integrator.

97 two samples, linkage evidence was increased to a maximum LOD score (MLS) of 4.3 (point-wise P = 4.34

98 ush, these cells started to die, progressing to a maximum loss of 57.8% +/- 8.1% of the cells in the

99 s of 10 nanomoles having virtually no effect to a maximum loss of 72.5% +/- 12.1% of the cells in the

100 A thorough parameter optimization led to a maximum methane chlorination rate of 0.8 mumol(CH(4

101 QCL drive current or strain pulse amplitude, to a maximum modulation depth of 6% in our experiment.

102 ce increases as the core volume increases up to a maximum near 2500 iron atoms, above which the size

103 eveloped in the Mpfrh1(lof) mutants compared to a maximum number of 7 observed in wild-type groups.

104 This amounts to a maximum observed factor of approximately 2.4 for ou

105 e/synapse density in hippocampal cultures up to a maximum of #x223c;40%, and when applied together at

106 higher to realize net benefits from CCS, up to a maximum of $910/ton.

107 ndent decreases in IL-1beta-stimulated PGE2, to a maximum of > 90% in all cell lines (P < or = 0.0001

108 e inhibition of catecholamine release ensued to a maximum of >80%.

109 ach correct response, assigned a value of +1 to a maximum of +7, was used to calculate a summary scor

110 In phase 1, plerixafor was escalated to a maximum of 0.24 mg/kg/d without any dose-limiting t

111 ites reveal that late accretion, constrained to a maximum of 0.5 +/- 0.2 per cent of Earth's silicate

112 D to 4.8 nM but only slightly increased Bmax to a maximum of 0.61 mol/mol-subunit.

113 the interlayer contrast (from 0.48 +/- 0.22 to a maximum of 0.89 +/- 0.05; P < 0.001) and thus allow

114 0.05 mol/mol protein, was found to increase to a maximum of 1 mol/mol in the presence of effectors.

115 f either 1 x 10(6) cells per kg body weight, to a maximum of 1 x 10(8) cells per infusion (cohort A),

116 The dose was increased to a maximum of 1,000 mg/d for up to 1 year.

117 111 cases per 100,000 person-years at entry to a maximum of 1,303 per 100,000 person-years at 5.2 ye

118 ould produce from 700 +/- 40 t/ha (measured) to a maximum of 1,940 +/- 230 t/ha (estimated) of grain

119 Caecal crypts accumulated dextran to a maximum of 1.8 +/- 0.17-fold above control levels.

120 ion ranged from a minimum of 2 g/d (control) to a maximum of 10 g/d after overfeeding.

121 as escalated based on treatment tolerability to a maximum of 10 mg/day, for 21 days/cycle, for a maxi

122 s facility and administered intravenously up to a maximum of 10 million cells/kg.

123 the length scale of a FRET ruler is limited to a maximum of 10 nm.

124 a base line of 5 pmol/nmol lipid phosphorus to a maximum of 10 pmol/nmol lipid phosphorus.

125 e assessed at baseline and every 9 months up to a maximum of 10 years.

126 rom a minimum of 2 x 10(-5) (BES resistance) to a maximum of 10(-3) (histidine independence) per dono

127 %, its effect at the field scale was limited to a maximum of 10.0%.

128 te of respiratory illness (all RI) increased to a maximum of 10.6 illnesses/infant/year in the 7- to

129 er randomisation for as long as possible, up to a maximum of 11 years.

130 Simulated individuals lived up to a maximum of 110 years.

131 Survival time was measured to a maximum of 12 hrs.

132 Patients could be enrolled up to a maximum of 12 months after tamoxifen initiation.

133 nal assessment of risk behaviors was limited to a maximum of 12 months.

134 eived treatment for at least 3 months and up to a maximum of 12 months.

135 al then was extended by 2 weeks at a time up to a maximum of 12 weeks.

136 y 2 weeks if there was no clinical activity, to a maximum of 12 weeks.

137 f treatment interval by 2 weeks at a time up to a maximum of 12 weeks.

138 7.5 mg thrice daily, with the dose increased to a maximum of 12.5 mg thrice daily, together with octr

139 dosterone increased RENCA cell proliferation to a maximum of 125 +/- 3% of control at a concentration

140 energies vary from approximately 2 kcal/mol to a maximum of 13.5 kcal/mol.

141 tervention was recommended for 7 days and up to a maximum of 14 days after randomization or until dis

142 Follow-up was from a minimum of 4 months to a maximum of 14 months.

143 r dependency for a minimum of 5 years and up to a maximum of 14 years after treatment of a ruptured i

144 Enhancement of IFN-gamma secretion increased to a maximum of 14-fold for VIP, 14-fold for the VIPR2-s

145 te increases from 127 beats per min at birth to a maximum of 145 beats per min at about 1 month, befo

146 nal progression into flanking DNA, typically to a maximum of 15 nucleotides into each flank.

147 L on a monthly or every other month schedule to a maximum of 16 injections.

148 Patients were given up to a maximum of 17 cycles of treatment.

149 , aldosterone increased RENCA cell migration to a maximum of 170 +/- 20% of control at a concentratio

150 The daily dose was titrated from 30 mg up to a maximum of 180 mg to achieve a reduction in serum i

151 cin 50 mg/m(2), and vincristine 1.4 mg/m(2) [to a maximum of 2 mg total dose] intravenously on day 1

152 ts aged 1-5 years received 0.7 mg/kg per day to a maximum of 2 mg/kg unless otherwise approved.

153 viral particles (vp) per dose and escalated to a maximum of 2 x 10(12) vp.

154 se of 300 mg orally per day in divided doses to a maximum of 2,400 mg or until relief from pruritus.

155 ard ratio increased with cumulative exposure to a maximum of 2-fold observed at 75 mg/m(3)-year strai

156 in, before increasing from 20% to 50% strain to a maximum of 2.9 MPa.

157 trexate alone titrated up from 7.5 mg a week to a maximum of 20 mg a week by week 8 or methotrexate (

158 During phase 1a, TY014 dose escalation to a maximum of 20 mg per kilogram of body weight occurr

159 born between 1996 and 2015 and followed them to a maximum of 20 years of age.

160 e data for COPD (2 years before diagnosis up to a maximum of 20 years, and 1 year after diagnosis) an

161 Aug 10, 2011, and followed up these patients to a maximum of 20 years.

162 increasing the temperature of the sample up to a maximum of 200 degrees C.

163 Sertraline hydrochloride was titrated to a maximum of 200 mg/d during the first 4 weeks of dou

164 Intake was titrated by the patient to a maximum of 21 capsules of either strength per day.

165 - 3.4 mm Hg higher at 12 weeks and increased to a maximum of 23.6 +/- 2.4 mm Hg at 24 weeks.

166 ith residents in subsequent years restricted to a maximum of 24 hrs.

167 iod, a 2 week dose titration phase from 5 mg to a maximum of 25 mg of tetrahydrocannabinol daily and

168 Study medication was progressively increased to a maximum of 25 mg twice daily during the next 4-6 we

169 We derived quality scores, scaled to a maximum of 25 per section (maximum total score=100)

170 on of +/-0.25 diopter, increased this number to a maximum of 25/50 comparisons (excluding pachymetry)

171 emperature (121 degrees C) for the material, to a maximum of 250 degrees C.

172 to receive oral metformin 500 mg (increasing to a maximum of 2500 mg) or matched placebo daily from b

173 [%ID] per gram for the analog with no spacer to a maximum of 26.97 +/- 3.97 %ID/g for the analog with

174 er simvastatin 80 mg or placebo daily for up to a maximum of 28 days, irrespective of coma or deliriu

175 Median follow-up time was 12.6 (to a maximum of 28.2) years.

176 .75% increments, every two to three breaths, to a maximum of 3.0%, with maintenance at 1.5%.

177 and increased stepwise every 4 weeks by 5 mg to a maximum of 30 mg per week, until remission or dose-

178 per day for patients of east-Asian heritage) to a maximum of 300 mg per day (150 mg per day for patie

179 ged over the patient's time in the trial (up to a maximum of 32 weeks).

180 were assessed daily until they occluded, up to a maximum of 35 days.

181 ally increased with increasing marker levels to a maximum of 36% to 47% at a bsT level of 28.0 mug/L,

182 ranging from approximately a minimum of 16% to a maximum of 39%, depending on the risk change consid

183 gel was inhibited in a dose-dependent manner to a maximum of 39%.

184 ks, with the duration of treatment escalated to a maximum of 4 weeks, followed by a 2-week rest perio

185 of H(2)(18)O increased in a saturable manner to a maximum of 4 x 10(5) s(-)(1), consistent with proto

186 ly distributed ranging from a minimum of 0.3 to a maximum of 4,000 Gy.

187 IOP in these two groups gradually increased to a maximum of 4.8 mm Hg (30%) at 36 weeks and was sign

188 (n = 140), starting at 10 mg/d and titrated to a maximum of 40 mg/d, or problem-solving treatment-pr

189 modified over time to permit dose increases to a maximum of 4000 mg/d peanut protein.

190 d rapamycin for a further 7, 14, or 21 days (to a maximum of 42 days after transplantation) after whi

191 Intrapatient dose escalations were allowed to a maximum of 450 mg/kg ideal body weight/d.

192 resolving power settings of 15k (7.8 Hz) up to a maximum of 480k (1.2 Hz).

193 ved 5% dextrose, from a minimum of 3 days up to a maximum of 5 days.

194 the first 24 hours from 10(6) at 4 hours up to a maximum of 5 x 10(6) EGFP-PMNs at 18 hours.

195 ed from a baseline of 0 in untreated animals to a maximum of 5.

196 plerenone (25 mg per day initially, titrated to a maximum of 50 mg per day; 3319 patients) or placebo

197 g of etanercept per kilogram of body weight (to a maximum of 50 mg), followed by 24 weeks of once-wee

198 increases of 10 mg/d weekly (flexible dosing to a maximum of 50 mg/d) permitted after the second week

199 ity (ranging from a minimum of 0.1-0.5 mug/L to a maximum of 50 mug/L), low limits of detection (0.01

200 hree FO membranes and with increasing TMP up to a maximum of 50 psi (3.45 bar).

201 In normally cultured CHO cells, up to a maximum of 50% of cells were permissive for BHK-pro

202 The dose was escalated from 180 microg/wk to a maximum of 540 microg/wk in 90-microg increments.

203 2 mg), arterial insulin levels quickly rose to a maximum of 55 +/- 6 or 92 +/- 9 microU/ml, respecti

204 ncreased with time, from 6-16% at 10 minutes to a maximum of 59-82% at 80-320 minutes.

205 meals one or three times daily for 4 weeks, to a maximum of 6 months, depending on disease response

206 A weighted scoring system (minimum of 0 to a maximum of 6 points) was subsequently developed.

207 ma pneumoniae ASCs were detected from 2 days to a maximum of 6 weeks after symptom onset, whereas Mp

208 in(-1) and were phase advanced and entrained to a maximum of 6.3 cycles min(-1) using 0.1 ms pulses o

209 pse were treated with daily infusions of ATO to a maximum of 60 doses or until all leukemic cells in

210 e basis of safety and tolerability from 5 mg to a maximum of 60 mg a day.

211 Zn2+ inhibited Cu2+ transport to a maximum of 60%, indicating that there may be more t

212 to 100 mg at weekly intervals, as tolerated to a maximum of 600 mg PO qhs.

213 meter from 90 microm to 200 microm centrally to a maximum of 600 microm in the periphery.

214 y to be tuned from 34.8 kJ/mol (for CaBTTri) to a maximum of 64.5 kJ/mol (MgBTT).

215 ed by more than two times, e.g., from 25 MPa to a maximum of 65 MPa, by simple agitation in aerated s

216 itially maintained and then slowly increased to a maximum of 7.6 g/dL on day 24 of therapy.

217 umor-to-background ratio increased with time to a maximum of 7.7 at 20 min.

218 number of secondary cases, increasing the EP to a maximum of 70%, and (4) decreasing the patient:HCW

219 in diameter from 70 to 150 microns centrally to a maximum of 700 microns in the periphery.

220 dramatically in a clear dose-related manner to a maximum of 73.7% +/- 6.7% at 10-6 M (p < 0.001).

221 n schedule was used with increasing doses up to a maximum of 8 mg/kg.

222 lurane introduced in 2% increments increased to a maximum of 8%, with maintenance at 4%.

223 ation of propranolol or placebo as tolerated to a maximum of 80 mg per day.

224 0 deaths among 5,204,433 people, followed up to a maximum of 80 years old) in relation to parental ag

225 ted at a daily dosage of 25 mg and increased to a maximum of 800 mg; the average was 258 mg (range, 5

226 s found to increase from 34% at 37 degrees C to a maximum of 84% at 80 degrees C.

227 days when kept at 34 degrees C in darkness, to a maximum of 852 days when stored at 21 degrees C in

228 Follow-up lasted up to a maximum of 9 years.

229 ciency at very low antigen concentration, up to a maximum of 91%, the amount of captured IL-6 increas

230 onductivity from one-third of the population to a maximum of 91%.

231 ased, the uptake of the compounds increased, to a maximum of 95% for the pentapeptide and 56%, 57% an

232 concentration of As increased from <1 mug/L to a maximum of 99 mug/L, exceeding the 10 mug/L limit f

233 ximately 3-fold in O2 species after 9 months to a maximum of a approximately 5.5-fold increase after

234 dels and unexpected, current-driven, strong (to a maximum of about 1340 m) downward displacement at d

235 of the RNA surrounding the poly(A) signal up to a maximum of about 200 nucleotides, which we infer to

236 increased in a fluence-rate-dependent manner to a maximum of about 75% inhibition at 50 mumol m-2 s-1

237 hibited by transfected wild-type p53 plasmid to a maximum of about 86%; (ii) p53 mediated a large par

238 tubules stimulate the rate of ATP hydrolysis to a maximum of approximately 15 s(-1).

239 e of blue light, stationary seedlings curved to a maximum of approximately 16 degrees about 80 minute

240 predicted, ATP inhibits Kir6.2[L164C/R176A] to a maximum of approximately 40%, with a clear plateau

241 g selectivity to specific sites may increase to a maximum of approximately 400-fold.

242 rged lipids, helical structure corresponding to a maximum of around 40 % of the extended S4 peptide i

243 lly on days 1, 2, 4, 5, 8, 9, 11, and 12) up to a maximum of eight cycles of 21 days or no treatment.

244 Cycles were repeated every 3 weeks to a maximum of eight cycles.

245 Limiting pediatric phase I trials to a maximum of four doses levels would significantly sh

246 or decreased at the clinician's discretion, to a maximum of four tablets and a minimum of one tablet

247 ll load parameters: after a gradual increase to a maximum of near 50%, it decreases with a further in

248 ts aged <20 y (</=4%) and increased with age to a maximum of nearly 15%.

249 t the release of neurotransmitter substances to a maximum of only 50-60% of the control level, sugges

250 Both regimens were repeated every 3 weeks to a maximum of seven cycles.

251 l dysplasias and expand from the normal five to a maximum of seven repeats.

252 atients were randomly assigned centrally 1:1 to a maximum of six 3-week cycles of gemcitabine and cis

253 en on days 1 through 14 of each 3-week cycle to a maximum of six cycles.

254 ence of cardiotoxicity by limiting treatment to a maximum of six cycles.

255 f repeat treatment courses should be limited to a maximum of three and the total dose to between 24 m

256 rion (BIC) to choose the number of groups up to a maximum of three.

257 romoted by negatively-charged beta chains up to a maximum of two additional net negative charges and

258 Incremental financial rewards, to a maximum of U.S. $1,650, were offered for biochemica

259 The KE increased d-beta-hydroxybutyrate to a maximum of ~3.4 mM (P < 0.001) during the OGTT.

260 , but both increased after the onset of ARDS to a maximum on Day 3 and remained elevated for as long

261 Such binding increased to a maximum on day 4 of culture, coinciding with the on

262 t to a 1800 Da linear dextran, corresponding to a maximum pore diameter of 2.6 nm.

263 ical genetic interval to 3 cM, corresponding to a maximum possible physical distance of 4.0 Mb.

264 ve angioedema could not be excluded, leading to a maximum potential risk of 30.5%.

265 sistance of the cell permitted to achieve up to a maximum power of 0.87mWcm(-2) (10.6mW) for pulses o

266 Pg by urokinase (uPA) approximately 20-fold, to a maximum rate indistinguishable from that for [Lys]P

267 fusion rate of 0.1 microg x kg(-1) x min(-1) to a maximum rate of 0.4 microg x kg(-1) x min(-1) and m

268 46C88) and titrated according to response up to a maximum rate of 0.4 mL/kg/hr with the objective to

269 imulate mantADP release from the second head to a maximum rate of 3.8 s-1.

270 ting with hydrogen for active sites, leading to a maximum reaction rate as a function of the H(2) pre

271 tunnelling regime are intrinsically limited to a maximum rectification ratio R of approximately 10(3

272 ure of this unusual TS in four crystal forms to a maximum resolution of 1.7 A.

273 y inhibitors, with and without F(-) present, to a maximum resolution of 2.1 A.

274 ansporter Gdx-Clo in complex with substrates to a maximum resolution of 2.3 angstrom.

275 raction data were collected from co-crystals to a maximum resolution of 2.40 A and refined to an R-fa

276 up to 87% at 297 +/- 2 K (which corresponds to a maximum RH of 70-86% inside the impactor).

277 d men (mean age=34 years) who were committed to a maximum security forensic hospital.

278 w/w of the "trapped" FAMEs, which would lead to a maximum shift in radiocarbon age of <3 years toward

279 ir first year of training are now restricted to a maximum shift length of 16 hrs, with residents in s

280 bi all with 100 % accuracy, which translates to a maximum speedup of 37.5, 23.1 and 11.6-fold for MSV

281 emperature programming from room temperature to a maximum temperature of 170 or 200 degrees C; the pr

282 III in isolated mitochondria first increased to a maximum then decreased as substrate supply was modu

283 ze and increasing the operating pressure led to a maximum time gain with a factor of 3.4, without com

284 tion received 15 fractions of proton therapy to a maximum total dose of 67.5 Gy equivalent.

285 s, or ramps, at rates from 10 V/s to 1 kV/s, to a maximum transmembrane potential of +/-1000 mV.

286 wild-type MotA, and speeds jumped from zero to a maximum value ( approximately 300 Hz) in one step.

287 coherence distance (t) approximately doubles to a maximum value (409 nm) from 10 mM NaCl to 154 mM Na

288 The amount of TCR down-regulation increases to a maximum value and then declines as a function of th

289 itudinal elastic modulus initially increased to a maximum value at about 3% MC and then decreased lin

290 sed with increasing protein expression level to a maximum value corresponding to a probe separation d

291 ing raindrop flattening limits raindrop size to a maximum value independent of air density, whereas r

292 reased from 0.25 +/- 0.02 for control strips to a maximum value of 0.31 +/- 0.04 at day 15 (p = 0.03)

293 the six-line radical adduct signal increased to a maximum value of 2.5-fold 2 h after administration

294 that the rate of CH(4) production increases to a maximum value related to magnetite catalyzation.

295 translation intensified, apoptosis increased to a maximum value.

296 The IM depot volume increased rapidly to a maximum volume at 2days post-GSK1265744 LAP adminis

297 ,2'-bipyridyl], the emitting color was tuned to a maximum wavelength of 540 nm (green).

298 mg/week, increased by 2.5 mg every 1-2 weeks to a maximum weekly dose of 20 mg by week 8) or placebo

299 circulating EPCs (after possibly increasing to a maximum) will decrease to low levels.

300 rs that increased significantly with drought to a maximum WUE(e) across all biomes; and a minimum nat